Experts investigating the relationship between the vaccine against coronavirus from AstraZeneca and clots have found no specific risk factors, including age, the European Union’s drug regulator said Wednesday. However, they clarified that they have been doing a more in-depth analysis.
”At this time, the test has not identified any specific risk factors, such as age, gender, or a previous medical history of bleeding disorders, for these very rare events.”Said the European Medicines Agency (EMA) in a statement.
On Tuesday, Germany became the latest in a series of countries to advise against the use of the AstraZeneca for the youngest after reports of some rare cases of clotting and despite the fact that the EMA says it’s safe.
“At this time, the test has not identified any specific risk factors, such as age, gender, or a previous medical history of bleeding disorders, for these very rare events.”The Amsterdam-based agency said in a statement.
A man receives a dose of the AstraZeneca / Oxford vaccine at a coronavirus vaccination center at the Wanda Metropolitano stadium in Madrid on March 24, 2021. (Photo by GABRIEL BOUYS / AFP). (GABRIEL BOUYS /)
“A causal relationship with the vaccine has not been demonstrated, but it is possible and analyzes continue to be carried out.yes, ”he added.